| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/LABINVEST.3780375 |
| P698 | PubMed publication ID | 11742032 |
| P50 | author | Francesc Mitjans | Q51786947 |
| Susana Castel | Q64495515 | ||
| P2093 | author name string | S Goodman | |
| F Huber | |||
| M Reina | |||
| S Vilaró | |||
| A Jonczyk | |||
| J Piulats | |||
| R Pagan | |||
| P2860 | cites work | Cell migration: a physically integrated molecular process | Q27860682 |
| Integrins: versatility, modulation, and signaling in cell adhesion | Q27860844 | ||
| Angiogenesis in cancer and other diseases | Q27861015 | ||
| Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment | Q29615852 | ||
| RGD and other recognition sequences for integrins | Q29616331 | ||
| Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels | Q29619679 | ||
| N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists | Q30580638 | ||
| Bidirectional signaling between the cytoskeleton and integrins | Q33597380 | ||
| The first step of adenovirus type 2 disassembly occurs at the cell surface, independently of endocytosis and escape to the cytosol | Q33809074 | ||
| Involvement of integrin alpha V gene expression in human melanoma tumorigenicity | Q34222036 | ||
| A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells | Q34691910 | ||
| Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin | Q35764323 | ||
| Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. | Q36234671 | ||
| Requirement of the NPXY motif in the integrin beta 3 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo. | Q36382612 | ||
| An Arg-Gly-Asp sequence within thrombin promotes endothelial cell adhesion | Q36529134 | ||
| Fluid-phase markers in the basolateral endocytic pathway accumulate in response to the actin assembly-promoting drug Jasplakinolide | Q36867083 | ||
| A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo | Q37366963 | ||
| Two integrin-binding peptides abrogate T cell-mediated immune responses in vivo | Q37593872 | ||
| Adenovirus endocytosis via alpha(v) integrins requires phosphoinositide-3-OH kinase | Q39577792 | ||
| RGD peptides induce apoptosis by direct caspase-3 activation. | Q40971438 | ||
| Moving membrane up to the front of migrating cells | Q41000793 | ||
| Ligation of integrin alpha5beta1 is required for internalization of vitronectin by integrin alphavbeta3. | Q41132432 | ||
| Integrin expression in human melanoma cell lines: heterogeneity of vitronectin receptor composition and function | Q41653482 | ||
| Basal detachment of the epidermis using dispase: tissue spatial organization and fate of integrin alpha 6 beta 4 and hemidesmosomes. | Q42504510 | ||
| The RGD-containing domain of exogenous HIV-1 Tat inhibits the engulfment of apoptotic bodies by dendritic cells. | Q45157658 | ||
| The actin cytoskeleton is required for receptor-mediated endocytosis in mammalian cells | Q46173335 | ||
| Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody. | Q52527988 | ||
| New way to activate caspases | Q58996631 | ||
| Determination of cell number in monolayer cultures | Q61703346 | ||
| Alpha v integrin antagonists induce the disassembly of focal contacts in melanoma cells | Q61918729 | ||
| Alpha v beta 5 integrin receptor-mediated endocytosis of vitronectin is protein kinase C-dependent | Q71703947 | ||
| RGD-containing peptides trigger apoptosis in glomerular mesangial cells of adult human kidneys | Q73398603 | ||
| Glycoprotein IIb/IIIa antagonists induce apoptosis in rat cardiomyocytes by caspase-3 activation | Q73462995 | ||
| In vivo therapy of malignant melanoma by means of antagonists of alphav integrins | Q74108530 | ||
| A new pseudo-peptide of Arg-Gly-Asp (RGD) with inhibitory effect on tumor metastasis and enzymatic degradation of extracellular matrix | Q74313529 | ||
| P433 | issue | 12 | |
| P921 | main subject | antibody | Q79460 |
| monoclonal antibody | Q422248 | ||
| P304 | page(s) | 1615-1626 | |
| P577 | publication date | 2001-12-01 | |
| P1433 | published in | Laboratory Investigation | Q6467260 |
| P1476 | title | RGD peptides and monoclonal antibodies, antagonists of alpha(v)-integrin, enter the cells by independent endocytic pathways | |
| P478 | volume | 81 |
| Q30995331 | A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice |
| Q42631171 | Angiostatin inhibits activation and migration of neutrophils. |
| Q27682746 | Atomic Basis for the Species-specific Inhibition of V Integrins by Monoclonal Antibody 17E6 Is Revealed by the Crystal Structure of V 3 Ectodomain-17E6 Fab Complex |
| Q34020465 | Biological Targeting of Plasmonic Nanoparticles Improves Cellular Imaging via the Enhanced Scattering in the Aggregates Formed |
| Q34715264 | Breaking the one antibody-one target axiom |
| Q37383038 | Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide. |
| Q91643705 | Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery |
| Q39518754 | Conjugation of cRGD peptide to chlorophyll a based photosensitizer (HPPH) alters its pharmacokinetics with enhanced tumor-imaging and photosensitizing (PDT) efficacy |
| Q39891843 | Derivation of a compartmental model for quantifying 64Cu-DOTA-RGD kinetics in tumor-bearing mice |
| Q30593039 | Determining Drug Efficacy Using Plasmonically Enhanced Imaging of the Morphological Changes of Cells upon Death. |
| Q41916835 | Endothelial cells internalize and degrade RGD-modified proteins developed for tumor vasculature targeting |
| Q41550095 | Enhancement of peptide coupling to hydroxyapatite and implant osseointegration through collagen mimetic peptide modified with a polyglutamate domain |
| Q39309330 | Fatty acid-RGD peptide amphiphile micelles as potential paclitaxel delivery carriers to α(v)β₃ integrin overexpressing tumors |
| Q39348354 | Guiding plant virus particles to integrin-displaying cells |
| Q52651546 | High expression of integrin αvβ3 enables uptake of targeted fluorescent probes into ovarian cancer cells and tumors. |
| Q45971787 | Immobilization of RGD peptide on HA coating through a chemical bonding approach. |
| Q44353071 | In vitro cell studies of technetium-99m labeled RGD-HYNIC peptide, a comparison of tricine and EDDA as co-ligands |
| Q40098490 | In vivo imaging of tumour angiogenesis in mice with the alpha(v)beta (3) integrin-targeted tracer 99mTc-RAFT-RGD. |
| Q34777281 | Inducing cancer cell death by targeting its nucleus: solid gold nanospheres versus hollow gold nanocages |
| Q42544946 | Integrin receptors on tumor cells facilitate NK cell-mediated antibody-dependent cytotoxicity |
| Q57599815 | Integrin-targeting with peptide-bioconjugated semiconductor-magnetic nanocrystalline heterostructures |
| Q36409214 | Integrins: molecular targets in cancer therapy |
| Q34036920 | Interfacial activity assisted surface functionalization: a novel approach to incorporate maleimide functional groups and cRGD peptide on polymeric nanoparticles for targeted drug delivery |
| Q39711810 | Intracellular targets of RGDS peptide in melanoma cells. |
| Q35197346 | MS-Monitored Conjugation of Poly(ethylene glycol) Monomethacrylate to RGD Peptides |
| Q40392045 | New multifunctional molecular conjugate vector for targeting, imaging, and therapy of tumors |
| Q35603108 | Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials. |
| Q34223126 | RGD modified polymers: biomaterials for stimulated cell adhesion and beyond |
| Q28543148 | RGDechi-hCit: αvβ3 selective pro-apoptotic peptide as potential carrier for drug delivery into melanoma metastatic cells |
| Q34129002 | Rosette nanotubes inhibit bovine neutrophil chemotaxis |
| Q93068998 | Size-Dependent Cellular Uptake of RGD Peptides |
| Q40579221 | Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX |
| Q92794475 | Synthesis and Biological Evaluation of RGD⁻Cryptophycin Conjugates for Targeted Drug Delivery |
| Q59795723 | Synthesis and photophysical studies of a multivalent photoreactive Ru-calix[4]arene complex bearing RGD-containing cyclopentapeptides |
| Q38867593 | Synthesis of a Cytotoxic Amanitin for Biorthogonal Conjugation |
| Q34238242 | Synthesis of biodegradable poly(ε-caprolactone)-organosiloxane hybrid with carboxylate groups |
| Q36952077 | Synthesis, characterization, and biological evaluation of integrin alphavbeta3-targeted PAMAM dendrimers. |
| Q34554287 | Targeted Vpr-derived peptides reach mitochondria to induce apoptosis of alphaVbeta3-expressing endothelial cells |
| Q46610587 | The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins |
| Q35562019 | Ultrasmall integrin-targeted silica nanoparticles modulate signaling events and cellular processes in a concentration-dependent manner |
| Q34282774 | microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4) |
Search more.